AI With Impact
From Imaging. To Insights. To Treatment.
Trusted by leading healthcare and technology partners
Clinical Evidence
Clinical evidence that translates into real-world clinical impact
80+
Peer-reviewed publications in leading journals.
11+
Years of clinical validation and real-world deployment.
3.5M+
Scans analyzed across stroke and lung imaging pathways.
18+
Regulatory clearances for clinical
use.
Peer-reviewed foundation
Brainomix solutions are underpinned by a strong portfolio of peer-reviewed studies demonstrating accuracy, reproducibility, and clinical validity across stroke and lung imaging.
Interviews
Why Customers Choose Brainomix
Deployed across 20+ countries, from regional hospitals to leading academic centres, helping clinicians make better, more informed treatment decisions every day.
View All Case Studies
12 May 2026
Brainomix and Boehringer Ingelheim Advance Strategic Partnership in Pulmonary Fibrosis
The two companies are broadening their partnership, building on strong results seen in...
02 Dec 2025
Diagnostic Software Triples Rate of Full Recovery in Stroke Patients
Specialized AI-assisted tool used on 60,000 people works up to an hour faster than traditional scans, allowing almost half to make...
16 Mar 2026
How Brainomix AI Has Changed Stroke Treatment at Örebro
Following deployment, survival rates are up and more patients are making a meaningful recovery from acute ischemic stroke. The SVT feature explores how AI-powered imaging changed clinical...
01 Sept 2025
AI brain scans help half of stroke patients fully recover
More than 60,000 people have had strokes diagnosed or ruled out since software was...
02 Dec 2025
Brainomix Announces New Study Published in Lancet Digital Health Demonstrating Impact of Brainomix 360 Stroke to Increase Endovascular Thrombectomy Rates
OXFORD, England and CHICAGO, December 2nd, 2025 – Brainomix, a global leader and...
06 Feb 2025
"Oxford Spinout Brainomix Is Revolutionising Stroke Care through AI"
The University of Oxford recently featured an article on Brainomix, highlighting the...
02 Sept 2025
How AI could triple likelihood of stroke patients making full recovery
Doctors say the new technology could triple the likelihood of recovery without a disability...
News & Insights
Value-Generating Partnerships —Over the years, Brainomix has formed key partnerships that broaden our reach, expand our portfolio, and deliver impactful solutions across stroke, lung diseases, and life sciences.
Clinical Evidence
For those who want to see how innovation translates into better outcomes for patients, here you can explore the science behind our technology, from AI validation and peer-reviewed studies to collaborative research and proven real-world impact.
Content Hub
Case studies, webinars, podcasts, and testimonials from across Brainomix. Hear directly from the clinicians and networks using our technology, and see the evidence behind it.
Born in Oxford
“In terms of the future, we are seeing that AI is transforming healthcare and we are part of this wave. With what we are doing now, we are seeing impact on a daily basis.”
Dr. Michalis Papadakis, CEO & Co-Founder, Brainomix
Life science
Bringing AI Precision to Every Stage of Clinical Trials
Brainomix's AI-powered quantitative imaging biomarkers and regulated software delivers value in clinical trials.
Core Partnership Areas
- Retrospective Trials
- Prospective Trials
- Real-World Evaluation
- Bespoke Development
Company
We are an award-winning pioneer of AI, leading the development of clinically proven imaging biomarkers that help improve outcomes and increase patient access to life-saving treatments.
Our Story
Pioneering AI-powered imaging biomarkers to enable precision medicine and help clinicians make more confident and informed treatment decisions.
Careers
Join a fast-growing Oxford spin-out advancing AI in stroke and lung diseases, and help transform patient outcomes worldwide with impactful technology.
ESG
We focus on ethical AI, patient safety, and responsible innovation to support sustainable and transparent healthcare systems.
Media Kit
Access official Brainomix logos, and imagery to support accurate, consistent coverage of our AI imaging technology across digital and print channels.
Support
Universal, Scalable, Trusted
Reliable support across clinical use, technical setup, and ongoing operation.
Brainomix Limited is a company registered in England and Wales at OX2 0JJ. Company Registration No. 07426406
Brainomix © 2026. All rights reserved